CAR T-cell therapyB7-H3-directed CAR T-cell therapyResiquimodPOx-RmedulloblastomaG3MB
…G3MB) is the most aggressive medulloblastoma subgroup. Although CAR T-cell therapy is promising, it has shown limited efficacy in G3MB due to poor…
8articles mentioning treatments
10treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: CAR T-cell therapy ×
CAR T-cell therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning CAR T-cell therapy
8 articles · page 1 of 1CAR T-cell therapysolid tumorsnephroblastomaosteosarcomahepatoblastomaAT/RTsextracranial malignant rhabdoid tumorsatypical teratoid/rhabdoid tumorsEwing sarcoma/other embryonal tumors
…DN6 as a target in pediatric tumors and their susceptibility to CAR T-cell therapy has yet to be established. This study aimed to evaluate the sui…
CAR T-cell therapySScRelma-celNCT06414135relmacabtagene autoleucel
…Introduction CAR T-cell therapy targeting CD19 has shown potential in autoimmune diseases such …
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
CAR T-cell therapyICANSUniversity College London Hospitalsviral encephalitisUCLHhaemato-oncology service
…neurological toxicity occurring in 50% of patients treated with CAR T-cell therapy. Advances in understanding its pathophysiology, recognition, an…
CAR T-cell therapyprostate cancerUniversity of Maryland, BaltimorePSMAATCC
…Background CAR T-cell therapy for prostate cancer presents several challenges, including poor…
CAR T-cell therapyaxi-celAxicabtagene Ciloleucelrelapse/refractory LBCL
…product features required to achieve durable response following CAR T-cell therapy are unknown. Here, we performed a comprehensive analysis encomp…
CAR T-cell therapyCAR-T therapyCD19 CAR T-cell therapyMayo clinic RochesterConsent
…Background CAR T-cell therapy has achieved remarkable responses in patients with relapsed/ref…